Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 3 fiscal years.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
INCHINN THERAPEUTICS from Charleroi, company number BE0799914755, closed financial year 2025 with a result of € 34,948 after tax. For that financial year INCHINN THERAPEUTICS recorded a gross margin of € 35,594 and equity of € -256,202. Compared with financial year 2024, the result moved from € -190,066 to € 34,948. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ -256,202
▲ € 34,948 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 34,948
▲ still € 190,066 loss in 2024
Profit after tax over the fiscal year.
€ 39,506
▲ € 33,389 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -266,202.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 300,000
Loans from banks and other lenders, long and short.
€ 6,987
▲ € 6,610 vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -109,558 | € -189,302 | € 35,594 | ▲ € 224,896 |
| Profit after taxes | € -111,084 | € -190,066 | € 34,948 | ▲ € 225,013 |
| Equity | € -101,084 | € -291,149 | € -256,202 | ▲ € 34,948 |
| Total debts | € 301,605 | € 300,706 | € 307,596 | ▲ 2% |
| Cash | € 187,075 | € 6,117 | € 39,506 | ▲ € 33,389 |
| Retained profit | € -111,084 | € -301,149 | € -266,202 | ▲ € 34,948 |
| Bank debt | € 300,000 | € 300,000 | € 300,000 | |
| Balance sheet total | € 200,522 | € 9,557 | € 51,394 | ▲ € 41,837 |
Key figures of INCHINN THERAPEUTICS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INCHINN THERAPEUTICS?
What happened at INCHINN THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 34,948. Source: NBB ↗
- Yannick Quesnel became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 111,084 loss in 2023 to € 34,948 profit in 2025.
Best year ever: 2025, with € 34,948 profit.
A new publication or filing at INCHINN THERAPEUTICS? We notify you, reason included.
Follow INCHINN THERAPEUTICSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind INCHINN THERAPEUTICS is Yannick Quesnel.
Directors
According to the 2025 annual accounts
Yannick Quesnel
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.914.755
- VAT number
- BE 0799.914.755
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- INCHINN THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 March 2023
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten